I’ll admit that I’m beginning to have my suspicions about the psychedelic sector. The question I’ve started asking when I look at a new psychedelics company is where’s the…
biosynthetic psilocybin
Mydecine Innovations Group (MYCO.NE) announced they have signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine. The research will be led by Dr. Matthew Johnson…
Cybin (CYBN.NE) announced they had completed their 20th pre-clinical study and are progressing their CYB003 and CYB004 proprietary psychedelic molecules into studies that will enable them to be tested…
Core One Labs (COOL.C) reported today that they’re ready to start biosynthetic production trials with psilocybin, according to a press release. The company’s Victoria-based subsidiary, Vocan Biotechnologies, finished developing…